Chakra Chennubhotla, PhD Profile Photo

Chakra Chennubhotla, PhD

CEO SpIntellx

Chakra co-founded SpIntellx to actualize the translational potential of these Pitt IP-fueled platforms. Chakra’s experience encompasses years in both industry and academia. He was the lead PI on several National Institutes of Health and National Science Foundation grants covering broad areas of bioimaging, molecular biophysics, computational and systems biology, and spatial intratumor heterogeneity. He holds several patents and has published extensively, appearing in Science Translational Medicine and Nature Communications, among other prominent journals.

April 30, 2022

Precision Pathology Using Explainable AI

2022 has turned out to be an extremely pivotal year for computational pathology with major announcements coming out of USCAP and …

Episode page